Free Trial
LON:SAV

Savannah Resources (SAV) Share Price, News & Analysis

GBX 3.80
+0.02 (+0.53%)
(As of 07/26/2024 ET)
Today's Range
3.66
3.80
50-Day Range
3.20
4.45
52-Week Range
1.50
5
Volume
2.74 million shs
Average Volume
3.36 million shs
Market Capitalization
£69.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SAV stock logo

About Savannah Resources Stock (LON:SAV)

Savannah Resources Plc explores for and develops mineral properties. It holds interests in Mutamba heavy mineral sands project in Mozambique; copper and gold projects in the Sultanate of Oman; and lithium projects located in Somero and Eräjärvi in Finland. Savannah Resources also has a 75% stake in the Mina do Barroso Project in northern Portugal. The company was formerly known as African Mining and Exploration plc and changed its name to Savannah Resources Plc in September 2013. Savannah Resources Plc was incorporated in 2010 and is based in London, the United Kingdom.

SAV Stock Price History

SAV Stock News Headlines

This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
Savannah Resources (LON:SAV) Stock Price Down 8%
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
See More Headlines
Receive SAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Savannah Resources and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2020
Today
7/26/2024

Industry, Sector and Symbol

Industry
Gold
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-3,450,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£35,325.00
Cash Flow
GBX 0.88 per share
Book Value
GBX 1 per share

Miscellaneous

Outstanding Shares
1,830,000,000
Free Float
N/A
Market Cap
£69.54 million
Optionable
Not Optionable
Beta
1.26
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. David Stuart Archer (Age 61)
    CEO & Director
  • Mr. Dale John Ferguson (Age 47)
    Technical Director & Director
  • Mr. Michael McGarty (Age 44)
    Chief Financial Officer
  • Mr. Stephen Frank Ronaldson (Age 63)
    Company Sec.
  • Dr. Durair A'Shaik
    Gen. Mang. Bus. Devel. - Oman

SAV Stock Analysis - Frequently Asked Questions

How have SAV shares performed this year?

Savannah Resources' stock was trading at GBX 2.10 at the beginning of the year. Since then, SAV stock has increased by 81.0% and is now trading at GBX 3.80.
View the best growth stocks for 2024 here
.

How were Savannah Resources' earnings last quarter?

Savannah Resources (LON:SAV) released its quarterly earnings data on Wednesday, March, 18th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.06.

How do I buy shares of Savannah Resources?

Shares of SAV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Savannah Resources own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Savannah Resources investors own include Rio Tinto Group (RIO), Prospex Oil and Gas (PXOG), JPMorgan Chase & Co. (JPM), Oxford Biomedica (OXB), Bacanora Lithium (BCN), Core Laboratories (CLB) and Clementia Pharmaceuticals (CMTA).

This page (LON:SAV) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners